reiterateCVXfinnhub
Evercore ISI Group Reiterates Outperform Rating on Chevron Corporation (CVX)
Evercore ISI Group reiterated its Outperform rating on Chevron Corporation (NYSE:CVX) on November 02, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Evercore ISI Group reiterated its Outperform rating on Chevron Corporation (NYSE:CVX) on November 02, 2026.
Read moreWells Fargo reiterated its Overweight rating on Chevron Corporation (NYSE:CVX) on November 02, 2026.
Read moreCantor Fitzgerald reiterated its Neutral rating on Palantir Technologies Inc. (NASDAQ:PLTR) on November 02, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Exxon Mobil Corporation (NYSE:XOM) on November 02, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Exxon Mobil Corporation (NYSE:XOM) on November 02, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) on November 02, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on AbbVie Inc. (NYSE:ABBV) on November 02, 2026.
Read moreWells Fargo reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) on November 02, 2026.
Read moreRBC Capital reiterated its Outperform rating on AbbVie Inc. (NYSE:ABBV) on November 02, 2026.
Read moreGuggenheim reiterated its Buy rating on AbbVie Inc. (NYSE:ABBV) on November 02, 2026.
Read moreStephens & Co. analysts upgraded Oracle Corporation (NYSE:ORCL) from Equal-Weight to Overweight on November 02, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Eli Lilly and Company (NYSE:LLY) on November 02, 2026.
Read moreWells Fargo reiterated its Overweight rating on Alphabet Inc. (NASDAQ:GOOG) on November 02, 2026.
Read moreWells Fargo reiterated its Overweight rating on Alphabet Inc. (NASDAQ:GOOGL) on November 02, 2026.
Read moreMelius Research reiterated its Buy rating on NVIDIA Corporation (NASDAQ:NVDA) on November 02, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Eli Lilly and Company (NYSE:LLY) on October 30, 2026.
Read moreWells Fargo reiterated its Overweight rating on Eli Lilly and Company (NYSE:LLY) on October 30, 2026.
Read moreTruist Securities reiterated its Buy rating on Eli Lilly and Company (NYSE:LLY) on October 30, 2026.
Read moreRBC Capital reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY) on October 30, 2026.
Read moreMorgan Stanley reiterated its Underweight rating on Bristol-Myers Squibb Company PFD CONV 2 (OTC:BMYMP) on October 30, 2026.
Read more